There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Title(s) as Introduced

ALS Placebo No More Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To ensure that ALS patients have access to treatment within clinical trials.


Actions Overview (1)

Date Actions Overview
12/18/2019Introduced in House

All Actions (3)

Date All Actions
12/19/2019Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
12/18/2019Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
12/18/2019Introduced in House
Action By: House of Representatives

Cosponsors (3)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Fitzpatrick, Brian K. [R-PA-1] 12/19/2019
Rep. Gallagher, Mike [R-WI-8] 12/19/2019
Rep. Green, Mark E. [R-TN-7] 02/28/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
House Energy and Commerce12/18/2019 Referred to
House Energy and Commerce Subcommittee on Health12/19/2019 Referred to

No related bill information was received for H.R.5480.


Subjects (5)


Latest Summary (1)

There is one summary for H.R.5480. View summaries

Shown Here:
Introduced in House (12/18/2019)

ALS Placebo No More Act

This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.